Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy

<p>Abstract</p> <p>Background</p> <p>Diagnosis of HIV infection is recently occurring with increasing frequency in middle-aged and in older individuals. As HAART became available, a minimal beneficial effect on immunological outcome in older in respect of younger subjec...

Full description

Bibliographic Details
Main Authors: Tamburrini Enrica, Montuori Eva, Bertagnolio Silvia, de Gaetano Donati Katleen, Rabagliati Ricardo, Tumbarello Mario, Tacconelli Evelina, Cauda Roberto
Format: Article
Language:English
Published: BMC 2004-11-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/4/46
id doaj-fe023f03921c48ccb07e8007bbc151af
record_format Article
spelling doaj-fe023f03921c48ccb07e8007bbc151af2020-11-25T01:42:59ZengBMCBMC Infectious Diseases1471-23342004-11-01414610.1186/1471-2334-4-46Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral TherapyTamburrini EnricaMontuori EvaBertagnolio Silviade Gaetano Donati KatleenRabagliati RicardoTumbarello MarioTacconelli EvelinaCauda Roberto<p>Abstract</p> <p>Background</p> <p>Diagnosis of HIV infection is recently occurring with increasing frequency in middle-aged and in older individuals. As HAART became available, a minimal beneficial effect on immunological outcome in older in respect of younger subjects has been reported. In fact, both the intensity and the rapidity of the immunological response appeared to be reduced in elderly subjects. On the contrary, only few reports have indicated a similar immunological outcome both in older and younger HIV-positive subjects. Interestingly, older age did not seem to significantly affect the long-term virological outcome of HAART treated subjects.</p> <p>Methods</p> <p>To characterise epidemiological and clinical features of older HIV+ subjects, a prospective case-control study was performed: 120 subjects ≥ 50 and 476 between 20 and 35 years were initially compared. Subsequently, to better define the impact of HAART on their viro-immunological response, 81 older were compared with 162 younger subjects.</p> <p>Results</p> <p>At baseline cases presented significantly lower TCD4+ cell number and were more frequently affected by comorbid conditions. Under HAART a statistically significant increase in TCD4+ cell number was observed in cases and controls. At multivariate analysis, there was no statistically significant difference between cases and controls regarding viro-immunological response.</p> <p>Conclusions</p> <p>Although older subjects present a more severe HIV infection, they can achieve, under HAART, the same viro-immunological success as the younger individuals.</p> http://www.biomedcentral.com/1471-2334/4/46
collection DOAJ
language English
format Article
sources DOAJ
author Tamburrini Enrica
Montuori Eva
Bertagnolio Silvia
de Gaetano Donati Katleen
Rabagliati Ricardo
Tumbarello Mario
Tacconelli Evelina
Cauda Roberto
spellingShingle Tamburrini Enrica
Montuori Eva
Bertagnolio Silvia
de Gaetano Donati Katleen
Rabagliati Ricardo
Tumbarello Mario
Tacconelli Evelina
Cauda Roberto
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy
BMC Infectious Diseases
author_facet Tamburrini Enrica
Montuori Eva
Bertagnolio Silvia
de Gaetano Donati Katleen
Rabagliati Ricardo
Tumbarello Mario
Tacconelli Evelina
Cauda Roberto
author_sort Tamburrini Enrica
title Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy
title_short Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy
title_full Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy
title_fullStr Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy
title_full_unstemmed Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy
title_sort older age does not influence cd4 cell recovery in hiv-1 infected patients receiving highly active anti retroviral therapy
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2004-11-01
description <p>Abstract</p> <p>Background</p> <p>Diagnosis of HIV infection is recently occurring with increasing frequency in middle-aged and in older individuals. As HAART became available, a minimal beneficial effect on immunological outcome in older in respect of younger subjects has been reported. In fact, both the intensity and the rapidity of the immunological response appeared to be reduced in elderly subjects. On the contrary, only few reports have indicated a similar immunological outcome both in older and younger HIV-positive subjects. Interestingly, older age did not seem to significantly affect the long-term virological outcome of HAART treated subjects.</p> <p>Methods</p> <p>To characterise epidemiological and clinical features of older HIV+ subjects, a prospective case-control study was performed: 120 subjects ≥ 50 and 476 between 20 and 35 years were initially compared. Subsequently, to better define the impact of HAART on their viro-immunological response, 81 older were compared with 162 younger subjects.</p> <p>Results</p> <p>At baseline cases presented significantly lower TCD4+ cell number and were more frequently affected by comorbid conditions. Under HAART a statistically significant increase in TCD4+ cell number was observed in cases and controls. At multivariate analysis, there was no statistically significant difference between cases and controls regarding viro-immunological response.</p> <p>Conclusions</p> <p>Although older subjects present a more severe HIV infection, they can achieve, under HAART, the same viro-immunological success as the younger individuals.</p>
url http://www.biomedcentral.com/1471-2334/4/46
work_keys_str_mv AT tamburrinienrica olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
AT montuorieva olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
AT bertagnoliosilvia olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
AT degaetanodonatikatleen olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
AT rabagliatiricardo olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
AT tumbarellomario olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
AT tacconellievelina olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
AT caudaroberto olderagedoesnotinfluencecd4cellrecoveryinhiv1infectedpatientsreceivinghighlyactiveantiretroviraltherapy
_version_ 1725033846598008832